ACI recovery from surgery to sport

Twelve to eighteen months — that is the realistic horizon from ACI implantation to return to high-impact sport. Most patients expect something closer to six months; the gap between that expectation and clinical reality is, according to a 2016 qualitative study (Toonstra et al., n=7), one of the most consistent sources of frustration and poor rehabilitation adherence after surgery.

The length is not a function of surgical complexity. It reflects graft biology: implanted chondrocytes need time to settle, proliferate, and gradually take on the mechanical load of the joint. No rehabilitation programme can meaningfully accelerate that process.

Four broad phases mark the journey. First, a protected weight-bearing period on crutches lasting roughly six to eight weeks. Second, active rehabilitation — building strength and range of motion from around two to six months. Third, progressive loading with low- and then moderate-impact activity between six and twelve months. Finally, a return-to-sport phase from twelve to eighteen months, once the graft is considered substantially mature.

Each phase is covered in the sections that follow.

Weeks one to eight: protecting the graft

Crutches are not optional in the first six to eight weeks — they are the mechanism by which the graft survives. Implanted chondrocytes cannot yet tolerate compressive load; placing weight through the joint before the cells have begun to integrate risks displacing or destroying the repair before it has taken hold. Most patients are either fully non-weight-bearing or permitted only toe-touch contact with the floor, depending on defect size and location.

What this period is not is rest. Physiotherapy-guided range-of-motion exercises begin from day one, and some protocols add a continuous passive motion (CPM) machine in the first days to weeks. Gentle, controlled movement circulates synovial fluid through the joint, which nourishes the graft without applying the compressive forces that crutch use is designed to avoid. The distinction — movement yes, load no — is clinically important and worth asking the surgical team to explain clearly before discharge.

The concrete target for this phase is full range of knee motion by approximately twelve weeks. Pain level alone is not the primary clinical marker; range of motion is. Patients who feel comfortable earlier than expected sometimes reduce their physiotherapy contact, which can jeopardise the ROM milestone.

Crutch dependence also has a practical dimension that tends to be underestimated. Toonstra et al. (2016) found, across seven ACI patients, that caregiver reliance was consistently greater than participants had anticipated before surgery — covering tasks as basic as shopping, driving, and managing stairs. Identifying that support network before the operation, not after, makes a material difference to how manageably this phase proceeds.

Months three to six: rebuilding strength and movement

By around the three-month mark, the crutches are gone and the rehabilitation effort shifts from protecting the graft to rebuilding the body around it.

Weight-bearing normalises gradually through this phase. Stationary cycling typically arrives first — low-force, rhythmic, and easy to calibrate — followed by swimming and pool-based hydrotherapy once the wound is fully healed. These activities place meaningful cardiovascular and muscular demand on the leg without the impact forces that would stress the still-maturing repair.

Quadriceps strength is the central clinical target of this phase. Without sufficient quadriceps conditioning, the graft alone cannot restore function: the muscle group absorbs load ahead of the joint surface, and rebuilding it is what makes later return to normal walking — and, eventually, sport — mechanically safe. Physiotherapy transitions from passive-assisted movement to active resistance work, with volume and load increasing week by week under therapist guidance.

Running is not part of this phase, and patients asking about jogging at the four-month mark should expect a firm redirect. Most patients are cleared to begin running somewhere between nine and twelve months, once the repair has matured sufficiently to tolerate impact loading. That milestone belongs to the next phase of rehabilitation.

Return to running and high-impact sport

Pain is a poor guide to biological readiness — the graft can feel comfortable long before it is mechanically mature enough to absorb impact. Graft maturation, driven by cellular remodelling rather than by symptoms, is what sets the clock.

Running is typically introduced between nine and twelve months post-implantation. High-impact activity — cutting, pivoting, jumping, and competition — is not cleared until twelve to eighteen months, when the repair is considered substantially complete. These are not worst-case estimates; they reflect the clinical norm across ACI, MACi, and STACi, all of which share the same biological maturation arc regardless of whether one or two operations were involved.

Return-to-sport decisions remain expert-driven and patient-specific, and no single validated test battery is applied universally — a genuine gap in the current evidence base. In practice, clinicians draw on a combination of concrete signals: limb-symmetry testing to confirm that quadriceps strength has recovered to an acceptable proportion of the uninjured side, functional movement assessment, time elapsed since implantation, and the specific physical demands of the sport. Rehabilitation textbooks describe four progressive phases — metabolic recovery, strength recovery, neuromuscular training, and on-field rehabilitation — with each phase assessed before the next is unlocked. Returning to sport too early, even in the absence of pain, risks mechanical failure of a graft that has not yet fully integrated.

For patients who complete the full arc, the long-term picture is encouraging: ACI achieves successful outcomes in approximately 82–85% of cases at extended follow-up.

Two-stage ACI vs single-stage STACi: what changes and what does not

Understanding ACI recovery requires a clear picture of how the two variants differ procedurally — because their differences are significant, even though their rehabilitation timelines are not.

Traditional ACI spreads the treatment across two separate operations. Stage 1 is an arthroscopic biopsy: a cartilage sample weighing roughly 200–300 mg is harvested from a non-weight-bearing zone of the joint and sent to a specialist laboratory. Over the following four to six weeks, chondrocytes are cultured and expanded to produce a cell supply approximately three times greater than an unprocessed harvest could yield. Stage 2 is the implantation — expanded cells are delivered under a periosteal or collagen patch, or pre-seeded onto a matrix as in MACi. That inter-stage interval, though it adds weeks to the total treatment journey, is not dead time: it can be used as a structured prehabilitation window, strengthening the quadriceps and conditioning the limb before the implantation surgery.

STACi — Single Treatment Autologous Chondrocyte Implantation, described by Taylor and Lee (2019) as the next generation of ACI — compresses both stages into one anaesthetic. Chondrocytes are harvested intraoperatively from a non-weight-bearing area of the joint, enzymatically isolated without altering their biological character, combined with mesenchymal stem cell-enriched bone marrow concentrate, loaded onto a collagen-hyaluronan scaffold, and implanted immediately. The gain is clear: one surgery, no laboratory wait, and no risk of chondrocyte dedifferentiation during prolonged culture. The trade-off is equally clear: the immediate cell yield is roughly one-third that of culture-expanded two-stage ACI, and long-term comparative outcome data are still accumulating. STACi is generally best suited to biologically younger patients — typically under 40 to 45 — with focal, containable defects; extensive or whole-joint damage falls outside its scope.

What does not change is the rehabilitation arc. As noted in s4, ACI, MACi, and STACi share the same post-operative pathway because the biological task — growing autologous chondrocytes into a stable repair — is identical. STACi removes the inter-stage wait and the second operation; it does not shorten the time the repaired tissue needs to mature.

The emotional and practical demands patients underestimate

Recovery from ACI demands more than physical endurance — the emotional toll of an eighteen-month arc is a clinical concern in its own right, not an afterthought.

A qualitative study by Toonstra and colleagues (2016) — seven participants at a mean of 8.7 months post-surgery, and the only published work to examine ACI patient experience directly — found that recovery is emotionally demanding in ways that consistently catch patients off guard. The finding that stood out most: reliance on caregivers was substantially heavier than participants had anticipated. Practical help with mobility, transport, and daily routines fell to family members and friends at a scale nobody had planned for before surgery.

This matters clinically because unmanaged expectations do not simply cause distress — they drive poor rehabilitation adherence. Patients who encounter an unexpectedly difficult phase at month four or five, without the context to recognise it as normal, are more likely to disengage from physiotherapy or misjudge what the joint is ready for.

Preoperative education is therefore an active clinical requirement. Patients who understand each phase before they enter it — what the crutch period requires of those around them, why low-impact exercise precedes running by months, where in the timeline motivation tends to dip — are better placed to complete the full arc.

That preparation begins at the candidacy assessment, where the appropriate technique — two-stage ACI, STACi, or an alternative approach — is matched to defect characteristics, biological age, and realistic activity goals. Specialist assessment is available at the London Cartilage Clinic via londoncartilage.com.